WilmerHale Represents Schrödinger in $232M IPO

WilmerHale Represents Schrödinger in $232M IPO

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

On February 10, 2020, Schrödinger, Inc., a scientific leader in developing chemical simulation software for use in pharmaceutical, biotechnology and materials research, announced the closing of its initial public offering of 13,664,704 shares of common stock at the public offering price of $17.00 per share, for total gross proceeds of approximately $232.3 million, including the underwriters’ exercise of its option to purchase additional shares. Schrödinger’s common stock commenced trading on the Nasdaq Global Market under the ticker symbol ‘SDGR’ on February 6, 2020.

The WilmerHale team representing Schrödinger includes Cynthia Mazareas, Steven Singer, Scott Lunin, Chip McCorkle, Andrea Sorrentino, Kim Wethly, Michael Lopes and Alexandra Noymer.

Read Schrödinger’s press release for more information.


Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel